Loading...
| A03973 | Pages: NA | Dec 2021 | 4479 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pharmaceutical Glycerine Market
Request Now !Pharmaceutical glycerine is an organic compound known as glycerol and glycerin, and is majorly used as an excipient in the pharmaceutical industry. Glycerine exhibits various benefits in medical and pharmaceutical preparations such as improving smoothness, lubrication, and humectant. It is most commonly utilized in formulation of suppositories, cough syrups, elixirs, and expectorants.
The rise in application of glycerine in treatment of increased eye pressure conditions such as glaucoma and during eye surgery fuels the market growth. Furthermore, increase in use of glycerine as a substitute for alcohol in herbal and botanical tincture preparation is anticipated to drive the market. In addition, increase in adoption of glycerine in pharmaceutical industry owing to its low cost and various medical benefits such as moisturizer in skin burns & minor skin irritations and in treatment of constipation. Moreover, it also exerts osmotic diuretic properties that support in the management of cerebral edema, reduce cerebrospinal pressure, and intraocular pressure. However, the adverse effects of pharmaceutical glycerine, such as diarrhoea, polyuria, nausea, dry mouth, and others hinder the market growth. Ongoing R&D activities related to pharmaceutical glycerine are anticipated to present new opportunities for the market.
The market is segmented on the basis of application, route of administration, and region. Based on application, the market is divided into excipient and drug. Based on route of administration, it is categorized into oral, rectal, intravenous, ophthalmic, and topical. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
List of players profiled in the report
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. EXCIPIENT
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Fillers & Plasticizer
4.2.4.1. Market size and forecast
4.2.5. Solubilizer & Emulsifier
4.2.5.1. Market size and forecast
4.2.6. Solvent
4.2.6.1. Market size and forecast
4.2.7. Coatings
4.2.7.1. Market size and forecast
4.2.8. Diluent & Base
4.2.8.1. Market size and forecast
4.2.9. Lubricant
4.2.9.1. Market size and forecast
4.2.10. Thickener
4.2.10.1. Market size and forecast
4.2.11. Sweetener
4.2.11.1. Market size and forecast
4.2.12. Others
4.2.12.1. Market size and forecast
4.3. DRUG
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Skin Care
4.3.4.1. Market size and forecast
4.3.5. Ophthalmic
4.3.5.1. Market size and forecast
4.3.6. Osmotic Diuretic
4.3.6.1. Market size and forecast
4.3.7. Others
4.3.7.1. Market size and forecast
CHAPTER 5 PHARMACEUTICAL GLYCERINE MARKET, BY ROUTE OF ADMINISTRATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ORAL
5.2.1. Market size and forecast
5.3. RECTAL
5.3.1. Market size and forecast
5.4. INTRAVENOUS
5.4.1. Market size and forecast
5.5. OPHTHALMIC
5.5.1. Market size and forecast
5.6. TOPICAL
5.6.1. Market size and forecast
CHAPTER 6 PHARMACEUTICAL GLYCERINE MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Pharmaceutical Glycerine Market by Application
6.2.5. North America Pharmaceutical Glycerine Market by Route of Administration
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Pharmaceutical Glycerine Market by Application
6.3.5. Europe Pharmaceutical Glycerine Market by Route of Administration
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Pharmaceutical Glycerine Market by Application
6.4.5. Asia-Pacific Pharmaceutical Glycerine Market by Route of Administration
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Latin America market size and forecast
6.5.3.2. Middle East market size and forecast
6.5.3.3. Africa market size and forecast
6.5.4. LAMEA Pharmaceutical Glycerine Market by Application
6.5.5. LAMEA Pharmaceutical Glycerine Market by Route of Administration
CHAPTER 7 COMPANY PROFILES
7.1. AEMETIS, INC.
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. ARCHER DANIELS MIDLAND COMPANY
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. CRODA INTERNATIONAL PLC
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. EMERY OLEOCHEMICALS GROUP
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. GODREJ GROUP
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. KAO CORPORATION
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. KUALA LUMPUR KEPONG BERHAD
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. PROCTER & GAMBLE CO.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. SAKAMOTO YAKUHIN KOGYO CO., LTD
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. THE DOW CHEMICAL COMPANY
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
